Ono Pharmaceutical
OPHLY5.0281.02% ( -0.052 )
Q1 FY2027 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Preview: Ono Pharmaceutical(OPHLY) predict that the Revenue is 717.3 M (-18.58%), Beat estimate;the EBIT is 189.28 M (+24.58%), Beat estimate;the EPS is 0.317 (+22.13%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.72B18.58%
0.69B21.40%
+0.02B2.82%
EBITExceed expectations
0.19B24.58%
0.15B1.74%
+0.04B26.32%
EPSExceed expectations
0.317422.13%
0.220215.27%
+0.097237.40%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf